BGPT: RumIc1S cleaves D-Ala-D-Ala reduces AF488-RumC1 binding on sacculi

Explore by Goal

Quick Explanation Copied

Key mechanism (supported by the provided RumC1/RumIc1S dataset)

RumIc1S is an extracellular protease (a soluble immunity domain) that provides immunity by cleaving the peptidoglycan stem at the D-Ala–D-Ala motif, reducing the availability/recognition of the substrate relevant to RumC1 action.
When D-Ala–D-Ala on/within PG is cleaved by RumIc1S, AF488-RumC1 binding on purified sacculi decreases (i.e., the RumC1 labeling signal is reduced).

Long Explanation

RumIc1S trims D-Ala–D-Ala → lowers RumC1 (AF488) binding on sacculi

Scientifically grounded, evidence-based mechanism map (using only facts present in the provided RumC1/RumIc1S dataset).

FIGURE 1 — Mechanistic flow (qualitative, evidence-linked)

Known from the provided dataset: RumC1 targets a transient nascent peptidoglycan intermediate and binds purified sacculi in fluorescent labeling experiments.
Known from the provided dataset: The immunity protein RumIc1S is a soluble extracellular domain that protects by cleaving the stem peptide, trimming the D-Ala–D-Ala motif.
Observed consequence described in the provided dataset: Cleavage by RumIc1S yields reduced AF488–RumC1 binding on sacculi (i.e., the fluorescent accumulation signal decreases).

FIGURE 2 — Evidence-to-claim checklist (what is directly supported)

Interpretation boundary

The dataset supports that RumIc1S trims D-Ala–D-Ala and that this corresponds to reduced AF488–RumC1 binding on sacculi. The dataset does not (in the provided excerpted material) quantify the fold-change in AF488 signal, nor does it specify the exact structural binding interface at atomic resolution for the cleaved vs uncleaved stem states.

FIGURE 3 — Context: why D-Ala–D-Ala is a recurring peptidoglycan motif

Why this matters for interpretation

D-Ala–D-Ala appears as a chemically meaningful terminus in peptidoglycan biology; in another bacterial context, an AmpR LTTR regulator binds the terminal D-Ala–D-Ala motif within UDP-MurNAc-pentapeptide. This supports biological plausibility that D-Ala–D-Ala-bearing structures are key informational/recognition elements across systems—without implying that RumC1 and AmpR share identical binding mechanisms.

Known unknowns / limitations (critical, evidence-bound)

Quantification gap: the provided material supports “reduced AF488–RumC1 binding” but (in what you gave me) does not include a numeric fold-change or full binding kinetics curve.
Mechanistic granularity gap: while the dataset indicates RumIc1S cleaves D-Ala–D-Ala, it may not specify exactly which RumC1-competent PG intermediate(s) are eliminated by the trimming in the sacculi preparation.
Generalizability: the mechanism is shown in Streptococcus pneumoniae with purified sacculi/protoplast contexts as described; extrapolation to other species or other PG architectures requires additional direct evidence.

Quick deep-dive buttons (BGPT)

Feedback:

Updated: April 27, 2026

Top Data Sources Export MCP

1. RumC1 is a broad-spectrum bacteriocin that binds nascent peptidoglycan and inhibits cell-wall synthesis in Streptococcus pneumoniae, with immunity provided by RumIc1 via extracellular proteolysis of the stem peptide and cross-resistance to vancomycin. [2026]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. This study reveals that the Citrobacter freundii AmpR regulator forms a tetramer with two high-affinity DNA-binding sites and can bind up to four UDP-MurNAc-pentapeptide repressor molecules, providing structural, biophysical, and mechanistic insight into how peptidoglycan metabolites regulate ampC β-lactamase expression through AmpR. [2015]

9QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

3. This study presents a solid-phase assay method for screening libraries of vancomycin mimics that selectively bind to d-Ala-d-Ala, addressing the urgent need for effective antibiotics against vancomycin-resistant bacteria. [1997]

7QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

4. The study demonstrates that adding hydrophobic hexapeptide side chains to des-N-methylleucyl glycopeptide hexapeptides drastically increases dimerization and membrane anchoring, compensating for reduced D-Ala-D-Ala binding in solution and markedly boosting antibacterial activity against both susceptible and resistant bacteria, via likely in vivo cooperative interactions at the cell-wall target. [2002]

8QualityResults Limitations Context Blindspots Methods Sample

↗ Paper Review ↗ Full Paper

5. The study shows that structural variations in the lipid II cell wall precursor modulate the binding and activity of the lipoglycopeptide antibiotic oritavancin, revealing additional target sites beyond D-Ala-D-Ala (including the crossbridge and D-iso-Gln) and explaining oritavancin’s potency against vancomycin-resistant strains. [2015]

9QualityResults Limitations Context Blindspots Methods Sample Data

↗ Paper Review ↗ Full Paper

Key Insight

RumIc1S immunity effectively “denoises” the RumC1 target landscape: by trimming D-Ala–D-Ala on the nascent-PG stem, it reduces the fraction of PG states that RumC1 can recognize and label—linking an extracellular proteolysis step directly to decreased fluorescent binding on sacculi.

Keep Exploring

Which specific nascent PG intermediate species (and their stem-terminus composition) are most responsible for RumC1 labeling, and how does RumIc1S shift the intermediate distribution on sacculi?

How do WalRK and LiaFSR perturbations alter the fraction of RumC1-competent PG states, and can that be linked to the timing of HADA incorporation changes during RumC1 exposure?

Does RumIc1S cleavage phenocopy any known D-D-carboxypeptidase activity patterns in peptidoglycan maturation, and what experimental readouts best disambiguate cleavage vs global PG remodeling?

Analysis Wizard

It will not run because the provided dataset contains only mechanistic summaries (no raw fluorescence/cleavage kinetics arrays) to compute numeric binding-reduction curves.

Hypothesis Graveyard

A “membrane disruption” explanation for reduced AF488–RumC1 binding would predict broad non-specific loss of labeling, but the dataset instead frames RumC1 as a cell-wall/nascent PG intermediate binder and RumIc1S as a stem-cleaving immunity factor; thus pure membrane effects are not the best fit to the provided evidence.

A “RumIc1S reduces AF488–RumC1 binding by simply quenching fluorescence” explanation is unlikely because RumIc1S is described as providing immunity via extracellular proteolysis of the PG stem peptide (a functional mechanism beyond fluorescence chemistry).

Potential Experiments

Quantify AF488–RumC1 sacculi binding reduction by measuring fluorescence intensity distributions (and band-to-band ratios) for: sacculi alone vs sacculi + active RumIc1S vs sacculi + inactive RumIc1S catalytic mutant; test whether cleavage of D-Ala–D-Ala is necessary for the binding loss.

Time-resolve the kinetics of RumIc1S trimming (D-Ala–D-Ala disappearance/appearance proxy) and correlate it with AF488–RumC1 binding accumulation on sacculi to determine causality ordering (cleavage first, then binding loss).

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may overweight the provided excerpt’s mechanistic framing (immunity proteolysis) because it is the only place where the exact RumIc1S→D-Ala–D-Ala→reduced binding chain is directly stated.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources Export MCP

1. RumC1 is a broad-spectrum bacteriocin that binds nascent peptidoglycan and inhibits cell-wall synthesis in Streptococcus pneumoniae, with immunity provided by RumIc1 via extracellular proteolysis of the stem peptide and cross-resistance to vancomycin. [2026]

3. This study presents a solid-phase assay method for screening libraries of vancomycin mimics that selectively bind to d-Ala-d-Ala, addressing the urgent need for effective antibiotics against vancomycin-resistant bacteria. [1997]

9. This study investigates the differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics, revealing that certain derivatives can inhibit the enzyme through mechanisms independent of traditional D-Ala-D-Ala binding. [2005]

11. This study characterizes a vancomycin-dependent Enterococcus faecium isolate from a bacteremic patient, revealing a unique mutation in the D-Ala-D-Ala ligase gene that confers vancomycin dependency and identifying various mechanisms of reversion in vitro. [2017]

12. This study demonstrates that exogenous D-alanine can inhibit the VanA ligase activity, thereby reducing vancomycin resistance in Streptomyces coelicolor and Enterococcus faecium, particularly in the absence of the D-Ala-D-Ala peptidase VanX. [2016]

Ask a Follow-Up

Key Insight

RumIc1S immunity effectively “denoises” the RumC1 target landscape: by trimming D-Ala–D-Ala on the nascent-PG stem, it reduces the fraction of PG states that RumC1 can recognize and label—linking an extracellular proteolysis step directly to decreased fluorescent binding on sacculi.

Keep Exploring

Which specific nascent PG intermediate species (and their stem-terminus composition) are most responsible for RumC1 labeling, and how does RumIc1S shift the intermediate distribution on sacculi?

How do WalRK and LiaFSR perturbations alter the fraction of RumC1-competent PG states, and can that be linked to the timing of HADA incorporation changes during RumC1 exposure?

Does RumIc1S cleavage phenocopy any known D-D-carboxypeptidase activity patterns in peptidoglycan maturation, and what experimental readouts best disambiguate cleavage vs global PG remodeling?

Analysis Wizard

It will not run because the provided dataset contains only mechanistic summaries (no raw fluorescence/cleavage kinetics arrays) to compute numeric binding-reduction curves.

Hypothesis Graveyard

A “RumIc1S reduces AF488–RumC1 binding by simply quenching fluorescence” explanation is unlikely because RumIc1S is described as providing immunity via extracellular proteolysis of the PG stem peptide (a functional mechanism beyond fluorescence chemistry).

Potential Experiments

Quantify AF488–RumC1 sacculi binding reduction by measuring fluorescence intensity distributions (and band-to-band ratios) for: sacculi alone vs sacculi + active RumIc1S vs sacculi + inactive RumIc1S catalytic mutant; test whether cleavage of D-Ala–D-Ala is necessary for the binding loss.

Time-resolve the kinetics of RumIc1S trimming (D-Ala–D-Ala disappearance/appearance proxy) and correlate it with AF488–RumC1 binding accumulation on sacculi to determine causality ordering (cleavage first, then binding loss).

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may overweight the provided excerpt’s mechanistic framing (immunity proteolysis) because it is the only place where the exact RumIc1S→D-Ala–D-Ala→reduced binding chain is directly stated.

Stay current without chasing every paper.

My BGPT

Trending

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Explanation Copied

Long Explanation

Top Data Sources ExportMCP

1. RumC1 is a broad-spectrum bacteriocin that binds nascent peptidoglycan and inhibits cell-wall synthesis in Streptococcus pneumoniae, with immunity provided by RumIc1 via extracellular proteolysis of the stem peptide and cross-resistance to vancomycin. [2026]

3. This study presents a solid-phase assay method for screening libraries of vancomycin mimics that selectively bind to d-Ala-d-Ala, addressing the urgent need for effective antibiotics against vancomycin-resistant bacteria. [1997]

9. This study investigates the differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics, revealing that certain derivatives can inhibit the enzyme through mechanisms independent of traditional D-Ala-D-Ala binding. [2005]

11. This study characterizes a vancomycin-dependent Enterococcus faecium isolate from a bacteremic patient, revealing a unique mutation in the D-Ala-D-Ala ligase gene that confers vancomycin dependency and identifying various mechanisms of reversion in vitro. [2017]

12. This study demonstrates that exogenous D-alanine can inhibit the VanA ligase activity, thereby reducing vancomycin resistance in Streptomyces coelicolor and Enterococcus faecium, particularly in the absence of the D-Ala-D-Ala peptidase VanX. [2016]

Ask a Follow-Up

Key Insight

RumIc1S immunity effectively “denoises” the RumC1 target landscape: by trimming D-Ala–D-Ala on the nascent-PG stem, it reduces the fraction of PG states that RumC1 can recognize and label—linking an extracellular proteolysis step directly to decreased fluorescent binding on sacculi.

Keep Exploring

Which specific nascent PG intermediate species (and their stem-terminus composition) are most responsible for RumC1 labeling, and how does RumIc1S shift the intermediate distribution on sacculi?

How do WalRK and LiaFSR perturbations alter the fraction of RumC1-competent PG states, and can that be linked to the timing of HADA incorporation changes during RumC1 exposure?

Does RumIc1S cleavage phenocopy any known D-D-carboxypeptidase activity patterns in peptidoglycan maturation, and what experimental readouts best disambiguate cleavage vs global PG remodeling?

Analysis Wizard

It will not run because the provided dataset contains only mechanistic summaries (no raw fluorescence/cleavage kinetics arrays) to compute numeric binding-reduction curves.

Hypothesis Graveyard

A “RumIc1S reduces AF488–RumC1 binding by simply quenching fluorescence” explanation is unlikely because RumIc1S is described as providing immunity via extracellular proteolysis of the PG stem peptide (a functional mechanism beyond fluorescence chemistry).

Potential Experiments

Quantify AF488–RumC1 sacculi binding reduction by measuring fluorescence intensity distributions (and band-to-band ratios) for: sacculi alone vs sacculi + active RumIc1S vs sacculi + inactive RumIc1S catalytic mutant; test whether cleavage of D-Ala–D-Ala is necessary for the binding loss.

Time-resolve the kinetics of RumIc1S trimming (D-Ala–D-Ala disappearance/appearance proxy) and correlate it with AF488–RumC1 binding accumulation on sacculi to determine causality ordering (cleavage first, then binding loss).

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I may overweight the provided excerpt’s mechanistic framing (immunity proteolysis) because it is the only place where the exact RumIc1S→D-Ala–D-Ala→reduced binding chain is directly stated.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP